← Evidence map

ArticleFrontiers in oncology2025

The oncometabolite R-2-hydroxyglutarate inhibits microglial activation via the FTO/NF-κB pathway.

Lu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41367876